Literature DB >> 9658075

In vitro cell-free conversion of noninfectious Moloney retrovirus particles to an infectious form by the addition of the vesicular stomatitis virus surrogate envelope G protein.

A Abe1, S T Chen, A Miyanohara, T Friedmann.   

Abstract

In the absence of envelope gene expression, retrovirus packaging cell lines expressing Moloney murine leukemia virus (MLV) gag and pol genes produce large amounts of noninfectious virus-like particles that contain reverse transcriptase, processed Gag protein, and viral RNA (gag-pol RNA particles). We demonstrate that these particles can be made infectious in an in vitro, cell-free system by the addition of a surrogate envelope protein, the G spike glycoprotein of vesicular stomatitis virus (VSV-G). The appearance of infectivity is accompanied by physical association of the G protein with the immature, noninfectious virus particles. Similarly, exposure in vitro of wild-type VSV-G to a fusion-defective pseudotyped virus containing a mutant VSV-G markedly increases the infectivity of the virus to titers similar to those of conventional VSV-G pseudotyped viruses. Furthermore, similar treatment of an amphotropic murine leukemia virus significantly allows infection of BHK cells not otherwise susceptible to infection with native amphotropic virus. The partially cell-free virus maturation system reported here should be useful for studies aimed at the preparation of tissue-targeted retrovirus vectors and will also aid in studies of nucleocapsid-envelope interactions during budding and of virus assembly and virus-receptor interactions during virus uptake into infected cells. It may also represent a potentially useful step toward the eventual development of a completely cell-free retrovirus assembly system.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9658075      PMCID: PMC109781     

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  39 in total

1.  Fusogenic virosomes prepared by partitioning of vesicular stomatitis virus G protein into preformed vesicles.

Authors:  P Hug; R G Sleight
Journal:  J Biol Chem       Date:  1994-02-11       Impact factor: 5.157

Review 2.  Expression of exogenous proteins in mammalian cells with the Semliki Forest virus vector.

Authors:  V M Olkkonen; P Dupree; K Simons; P Liljeström; H Garoff
Journal:  Methods Cell Biol       Date:  1994       Impact factor: 1.441

3.  Characterization of the putative fusogenic domain in vesicular stomatitis virus glycoprotein G.

Authors:  L Zhang; H P Ghosh
Journal:  J Virol       Date:  1994-04       Impact factor: 5.103

4.  Assembly of rubella virus structural proteins into virus-like particles in transfected cells.

Authors:  T C Hobman; M L Lundstrom; C A Mauracher; L Woodward; S Gillam; M G Farquhar
Journal:  Virology       Date:  1994-08-01       Impact factor: 3.616

5.  Vesicular stomatitis virus G glycoprotein pseudotyped retroviral vectors: concentration to very high titer and efficient gene transfer into mammalian and nonmammalian cells.

Authors:  J C Burns; T Friedmann; W Driever; M Burrascano; J K Yee
Journal:  Proc Natl Acad Sci U S A       Date:  1993-09-01       Impact factor: 11.205

6.  A general method for the generation of high-titer, pantropic retroviral vectors: highly efficient infection of primary hepatocytes.

Authors:  J K Yee; A Miyanohara; P LaPorte; K Bouic; J C Burns; T Friedmann
Journal:  Proc Natl Acad Sci U S A       Date:  1994-09-27       Impact factor: 11.205

7.  Vesicular stomatitis virus glycoprotein mutations that affect membrane fusion activity and abolish virus infectivity.

Authors:  B L Fredericksen; M A Whitt
Journal:  J Virol       Date:  1995-03       Impact factor: 5.103

8.  Vesicular stomatitis virus glycoprotein is sorted and concentrated during export from the endoplasmic reticulum.

Authors:  W E Balch; J M McCaffery; H Plutner; M G Farquhar
Journal:  Cell       Date:  1994-03-11       Impact factor: 41.582

9.  Mutational analysis of the vesicular stomatitis virus glycoprotein G for membrane fusion domains.

Authors:  Y Li; C Drone; E Sat; H P Ghosh
Journal:  J Virol       Date:  1993-07       Impact factor: 5.103

10.  Novel infectious particles generated by expression of the vesicular stomatitis virus glycoprotein from a self-replicating RNA.

Authors:  M M Rolls; P Webster; N H Balba; J K Rose
Journal:  Cell       Date:  1994-11-04       Impact factor: 41.582

View more
  12 in total

1.  Pseudotyping of glycoprotein D-deficient herpes simplex virus type 1 with vesicular stomatitis virus glycoprotein G enables mutant virus attachment and entry.

Authors:  D B Anderson; S Laquerre; K Ghosh; H P Ghosh; W F Goins; J B Cohen; J C Glorioso
Journal:  J Virol       Date:  2000-03       Impact factor: 5.103

2.  Separable mechanisms of attachment and cell uptake during retrovirus infection.

Authors:  S Sharma; A Miyanohara; T Friedmann
Journal:  J Virol       Date:  2000-11       Impact factor: 5.103

3.  Determination of infectious retrovirus concentration from colony-forming assay with quantitative analysis.

Authors:  Young Jik Kwon; Gene Hung; W French Anderson; Ching-An Peng; Hong Yu
Journal:  J Virol       Date:  2003-05       Impact factor: 5.103

4.  Murine retroviral pseudotype virus containing hepatitis B virus large and small surface antigens confers specific tropism for primary human hepatocytes: a potential liver-specific targeting system.

Authors:  Vicky M H Sung; Michael M C Lai
Journal:  J Virol       Date:  2002-01       Impact factor: 5.103

5.  A small-molecule-controlled system for efficient pseudotyping of prototype foamy virus vectors.

Authors:  Yu-Ping Ho; Viktor Schnabel; Anka Swiersy; Kristin Stirnnagel; Dirk Lindemann
Journal:  Mol Ther       Date:  2012-04-03       Impact factor: 11.454

6.  Relationship between SU subdomains that regulate the receptor-mediated transition from the native (fusion-inhibited) to the fusion-active conformation of the murine leukemia virus glycoprotein.

Authors:  Dimitri Lavillette; Alessia Ruggieri; Bertrand Boson; Marielle Maurice; François-Loïc Cosset
Journal:  J Virol       Date:  2002-10       Impact factor: 5.103

7.  Blockade of type I interferon (IFN) production by retroviral replicating vectors and reduced tumor cell responses to IFN likely contribute to tumor selectivity.

Authors:  Amy H Lin; Cindy Burrascano; Par L Pettersson; Carlos E Ibañez; Harry E Gruber; Douglas J Jolly
Journal:  J Virol       Date:  2014-06-25       Impact factor: 5.103

8.  Human immunodeficiency virus type 1-derived lentivirus vectors pseudotyped with envelope glycoproteins derived from Ross River virus and Semliki Forest virus.

Authors:  Christoph A Kahl; Jon Marsh; Joanne Fyffe; David A Sanders; Kenneth Cornetta
Journal:  J Virol       Date:  2004-02       Impact factor: 5.103

9.  Autophagy is an essential component of Drosophila immunity against vesicular stomatitis virus.

Authors:  Spencer Shelly; Nina Lukinova; Shelly Bambina; Allison Berman; Sara Cherry
Journal:  Immunity       Date:  2009-04-09       Impact factor: 31.745

10.  Enhanced transgenesis by intracytoplasmic injection of envelope-free lentivirus.

Authors:  Shang-Hsun Yang; Yuksel Agca; Pei-Hsun Cheng; Jin-Jing Yang; Cansu Agca; Anthony Wing Sang Chan
Journal:  Genesis       Date:  2007-04       Impact factor: 2.487

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.